Skip to main content
logo
Vicore Pharma Holding AB (publ) (STO:VICO)
Sweden flag Sweden · Delayed Price · Currency is SEK
11.22
+0.04 (0.36%)
Jul 24, 2026, 5:29 PM CET

Vicore Pharma Holding AB Revenue

Vicore Pharma Holding AB had revenue of 602.00K SEK in the quarter ending March 31, 2026, a decrease of -32.51%. This brings the company's revenue in the last twelve months to 3.53M, down -41.17% year-over-year. In the year 2025, Vicore Pharma Holding AB had annual revenue of 3.82M, down -96.51%.

Revenue (ttm)
3.53M
Revenue Growth
-41.17%
P/S Ratio
895.58
Revenue / Employee
88.18K
Employees
40
Market Cap
3.16B

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20253.82M-105.53M-96.51%
Dec 31, 2024109.35M--
Dec 31, 20230--
Dec 31, 20220--
Dec 31, 20210--
Dec 31, 20200--
Dec 31, 20190--
Dec 31, 2018508.00K-424.00K-45.49%
Dec 31, 2017932.00K80.00K9.39%
Dec 31, 2016852.00K12.00K1.43%
Dec 31, 2015840.00K-11.00K-1.29%
Dec 31, 2014851.00K-2.36M-73.48%
Dec 31, 20133.21M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Saniona AB429.29M
BioInvent International AB217.86M
Hansa Biopharma AB189.46M
Genovis AB (publ.)142.12M
Egetis Therapeutics AB63.10M
Medivir AB9.01M
Xspray Pharma AB2.47M
Infant Bacterial Therapeutics AB-1.00K
Revenue Rankings

Vicore Pharma Holding AB News

More News